Sarah Zierold

Statistics

Publications

Citations

286

H-Index

Active since

2021

Affiliations

Ludwig-Maximilians-Universität München(Current)

Universitätsklinikum Erlangen

University of Miami

LMU Klinikum

Friedrich-Alexander-Universität Erlangen-Nürnberg

Sarah Zierold is an author at Ludwig-Maximilians-Universität München specializing in oncology, immune checkpoint inhibitor therapy, and immunotherapy.

Publications per year

2021–2024

Publications

Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life

Thomas U. Schulz, Sarah Zierold, Michael Sachse et al. · European Journal of Cancer · 2022 · 75 citations · Full text

Life Sciences, Immunology, Oncology +16

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

Theresa Ruf, Rafaela Kramer, Andrea Forschner et al. · European Journal of Cancer · 2024 · 47 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors

Dirk Tomsitz, Theresa Ruf, Sarah Zierold et al. · Cancers · 2023 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Leonie Müller‐Jensen, Sarah Zierold, Judith M. Versluis et al. · European Journal of Cancer · 2022 · 38 citations · Full text

Medicine, Neurology, Oncology +17

Brain‐Derived Neurotrophic Factor Expression and Signaling in Different Perivascular Adipose Tissue Depots of Patients With Coronary Artery Disease

Sarah Zierold, K. Buschmann, Sogol Gachkar et al. · Journal of the American Heart Association · 2021 · 31 citations · Full text

Life Sciences, Cardiology, Molecular Biology +16

1–5 of 9